Filing Details
- Accession Number:
- 0001628280-24-048416
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-19 16:06:12
- Reporting Period:
- 2024-11-18
- Accepted Time:
- 2024-11-19 16:06:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1699031 | Grail Inc. | GRAL | Services-Medical Laboratories (8071) | 863673636 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2024196 | Aaron Freidin | C/O Grail, Inc. 1525 O'Brien Drive Menlo Park CA 94025 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-18 | 30,452 | $14.02 | 268,277 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price calculated by the broker executing the sell-to-cover transactions. These shares were sold as part of a block trade in multiple transactions, and the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price.
Billionaire Hedge Funds
